Delivery Order SPE2DB20D3101-SPE2DB24FRDK0
Award Date 3/8/24
Potential Completion Date 3/11/24
Potential Value $1.5K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,192.67 for 4,559,700,837 units of NARCAN 4 MG NASAL SPRAY 2S. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD), and has an ultimate completion date of January 25, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of NARCAN 4 MG NASAL SPRAY 2S. The $1,463.04 firm-fixed-price delivery order has an ultimate completion date of August 21, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that specializes in supplying medical products to federal government agencies, including the Department of Defense (DoD) and Department of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of NARCAN 4 MG NASAL SPRAY 2S. The firm-fixed-price delivery order, valued at $4,097.74, has a completion date of February 8, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., the parent company. The contract is part of a larger Indefinite Delivery Contract (IDC)...
- This contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical pharmaceutical product. The contract has a ceiling value of $18,106.62 and was awarded by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of April 16, 2024. The contract is a Delivery Order on a Firm Fixed Price basis, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds...
- This federal contract award is for the supply of NARCAN 4 MG NASAL SPRAY 2S to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with no set-aside designation. The contract has a ceiling value of $16,835.44 and an ultimate completion date of February 27, 2024. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., has established itself as a key vendor for...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of NARCAN 4 MG NASAL SPRAY 2S. The $2,354.53 firm-fixed-price contract has an ultimate completion date of January 25, 2023. Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,959.32 firm fixed-price delivery order is for NARCAN 4 MG NASAL SPRAY 2S, with a performance completion date of December 16, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of NARCAN 4 mg nasal spray to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $2,344.97, is a firm fixed-price delivery order with a completion date of January 30, 2023. There is no set-aside designation for this contract. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc.,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $10,944.80, is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdoses. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of February 13, 2024. The contract is not designated with a set-aside requirement, indicating open...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,564.64, is a delivery order for 4,560,883,236 units of NARCAN 4 MG NASAL SPRAY 2S. This order falls under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. The IDC...